Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 187,400 | 114,500 | 385,200 | 274,300 | 178,100 |
| Depreciation Amortization | 59,800 | 30,900 | 110,500 | 81,100 | 53,000 |
| Income taxes - deferred | -6,300 | -2,700 | 69,000 | 54,900 | 13,500 |
| Accounts receivable | -49,200 | -20,500 | -33,600 | -35,600 | -11,900 |
| Accounts payable and accrued liabilities | -46,300 | -50,300 | 33,600 | -47,300 | -41,400 |
| Other Working Capital | -314,300 | -196,500 | -222,400 | -312,500 | -244,300 |
| Other Operating Activity | 140,500 | 65,100 | 35,900 | 97,700 | 78,200 |
| Operating Cash Flow | $-28,400 | $-59,500 | $378,200 | $112,600 | $25,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 8,600 | 39,600 | -125,000 | -89,300 | -58,000 |
| Net Acquisitions | N/A | N/A | -685,100 | -680,600 | -674,400 |
| Sale Of Investment | 1,500 | N/A | 2,000 | 2,000 | 2,000 |
| Other Investing Activity | 0 | 0 | 6,000 | 6,000 | 6,000 |
| Investing Cash Flow | $10,100 | $39,600 | $-802,100 | $-761,900 | $-724,400 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 7,500 | 2,300 | -27,600 | -27,700 | -22,700 |
| Debt Issued | 495,900 | N/A | 605,800 | 605,800 | 592,900 |
| Debt Repayment | -571,000 | -294,800 | -10,300 | -10,300 | 0 |
| Common Stock Issued | 87,000 | 29,500 | 112,700 | 90,800 | 79,500 |
| Dividend Paid | -72,400 | -36,100 | -130,100 | -97,300 | -64,700 |
| Other Financing Activity | 7,200 | 4,500 | 13,700 | 10,400 | 3,500 |
| Financing Cash Flow | $-45,800 | $-294,600 | $564,200 | $571,700 | $588,500 |
| Exchange Rate Effect | 11,500 | 13,900 | 7,100 | 6,800 | 1,700 |
| Beginning Cash Position | 365,700 | 365,700 | 218,300 | 218,300 | 218,300 |
| End Cash Position | 313,100 | 65,100 | 365,700 | 147,500 | 109,300 |
| Net Cash Flow | $-52,600 | $-300,600 | $147,400 | $-70,800 | $-109,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,400 | -59,500 | 378,200 | 112,600 | 25,200 |
| Capital Expenditure | -61,400 | -26,000 | -136,500 | -95,900 | -58,700 |
| Free Cash Flow | -89,800 | -85,500 | 241,700 | 16,700 | -33,500 |